Synlogic Inc

NASDAQ:SYBX USA Biotechnology
Market Cap
$7.84 Million
Market Cap Rank
#33345 Global
#10892 in USA
Share Price
$0.67
Change (1 day)
+11.67%
52-Week Range
$0.56 - $1.83
All Time High
$990.15
About

Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-system… Read more

Synlogic Inc (SYBX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.139x

Based on the latest financial reports, Synlogic Inc (SYBX) has a cash flow conversion efficiency ratio of -0.139x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.44 Million) by net assets ($10.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Synlogic Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Synlogic Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Synlogic Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Synlogic Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Synlogic Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Synlogic Inc from 2013 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $12.75 Million $-31.66 Million -2.483x -105.18%
2023-12-31 $42.66 Million $-51.61 Million -1.210x -75.72%
2022-12-31 $82.61 Million $-56.89 Million -0.689x -94.28%
2021-12-31 $147.27 Million $-52.20 Million -0.354x -3.18%
2020-12-31 $115.14 Million $-39.55 Million -0.344x +28.58%
2019-12-31 $156.91 Million $-75.47 Million -0.481x -40.54%
2018-12-31 $124.10 Million $-42.47 Million -0.342x +6.29%
2017-12-31 $85.04 Million $-31.05 Million -0.365x +11.15%
2016-12-31 $60.35 Million $-24.80 Million -0.411x -65.33%
2015-12-31 $85.02 Million $-21.14 Million -0.249x -185.33%
2014-12-31 $-47.95 Million $-13.97 Million 0.291x +34.16%
2013-12-31 $-29.91 Million $-6.50 Million 0.217x --